Review of this manuscript was directed by Associate Editor Hermes A. Kontos.
M.L.D., Editor-in-Chief, Stroke Journal, Department of Neurology, Indiana University School of Medicine, Indianapolis; H.J.M.B., Principal Investigator, Canadian Aspirin Trial, The John P. Robarts Research Institute, London, Ontario, Canada; J.D.E., Chairman, Stroke Council, American Heart Association, Department of Neurology, Brown University School of Medicine, Providence, R.I.; W.S.F., Principal Investigator, United States Aspirin Trial, Professor Emeritus of Neurology, University of Texas Health Science Center, Houston; V.F., Chairman, Writing Group for Aspirin Papers, American Heart Association, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, Mass.; V.H., Chairman, International Joint Conferences on Stroke and Cerebral Circulation 1987-1991, Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada; J.W.N., Director, Stroke Research Unit, Sunnybrook Medical Center, University of Toronto, Canada; and D.G.S., Chairman, International Joint Conferences on Stroke and Cerebral Circulation 1992-1996, Department of Medicine/Neurology, University of Texas, San Antonio.
Address for correspondence: Mark L. Dyken, Stroke Editorial Office, Indiana University School of Medicine, Department of Neurology, Bryce Bldg., 2nd Floor, Room 8, 1001 W. 10th Street, Indianapolis, IN 46202-2879.
